. "B4. Potential Contraceptive Effects of Antigestogens." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
Luukkainen, T., Heikinheimo, O., Haukkamaa, M., et al. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertility and Sterility 49:961–963, 1988.
Neulen, J., Williams, R.F., and Hodgen, G.D. RU 486 (mifepristone) induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. Journal of Clinical Endocrinology and Metabolism 71:1074–1075, 1990.
Norman, J.E., Thong, K.J., and Baird, D.T. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 338:1233–1236, 1991.
Permezel, J.M., Lenton, E.A., Roberts, I., et al. Acute effects of progesterone and the antiprogestin RU 486 on gonadotrophin secretion in the follicular phase of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 68:960–965, 1989.
Philibert, D., Deraedt, R., Tournemine, C., et al. RU 38486—an antiglucocorticoid with a new mechanism of antihormone activity. Journal of Steroid Biochemistry 17:68, 1982.
Rimmer, C., Horga, M., Cerar, V., et al. Do women want a once-a-month pill? Human Reproduction 7:608–611, 1992.
Schaison, G., George, M., Lestrat, N., et al. Effects of the antiprogesterone steroid RU 486 during the midluteal phase in normal women. Journal of Clinical Endocrinology and Metabolism 61:484–489, 1985.
Shoupe, D., Mishell, D.R., Page, M.A., et al. Effects of the antiprogesterone RU 486 in normal women. II: Administration in the late follicular phase. American Journal of Obstetrics and Gynecology 157:1421–1426, 1987.
Spitz, I.M., Croxatto, H.B., Salvatierra, A.M., et al. Response to intermittent RU 486 in women. Fertility and Sterility 1993 (in press).
Stuenkel, C.A., Liu, J.H., Gorzo, V.G., et al. Effects of the antiprogesterone RU 486 in the early follicular phase of the menstrual cycle. Fertility and Sterility 53:642–646, 1990.
Swahn, M.L., Johannison, E., Danoire, V., et al. The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and endometrium. Human Reproduction 3:915–921, 1988.
Swahn, M.L., Bygdeman, M., Cekan, S., et al. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormone parameters and endometrium. Human Reproduction 5:402–408, 1990.
Thong, K.J., and Baird, D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. British Journal of Obstetrics and Gynaecology 99:1004–1007, 1992.
van Santen, M.R., and Haspels, A.A. Interception IV: Failure of mifepristone (RU 486) as a monthly contragestive, "lunarette." Contraception 35:433–438, 1987.
van Uem, J.F., Hsiu, J.G., Chillik, C.F., et al. Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception 40:171–183, 1989.
Webb, A.M.C., Russel, J., and Elstein, M. Comparison of Yuzpe regimen, danazol and mifepristone (RU 486) in oral post coital contraception. British Medical Journal 305:927–931, 1992.
World Health Organization (WHO). Unpublished data, 1993.